Derivation of attenuation map for attenuation correction of PET data in the presence of nanoparticulate contrast agents using spectral CT imaging
- 247 Downloads
Uptake value in quantitative PET imaging is biased due to the presence of CT contrast agents when using CT-based attenuation correction. Our aim was to examine spectral CT imaging to suppress inaccuracy of 511 keV attenuation map in the presence of multiple nanoparticulate contrast agents.
Using a simulation study we examined an image-based K-edge ratio method, in which two images acquired from energy windows located above and below the K-edge energy are divided by one another, to identify the exact location of all contrast agents. Multiple computerized phantom studies were conducted using a variety of NP contrast agents with different concentrations. The performance of the proposed methodology was compared to conventional single-kVp and dual-kVp methods using wide range of contrast agents with varying concentrations.
The results demonstrate that both single-kVp and dual-kVp energy mapping approaches produce inaccurate attenuation maps at 511 keV in the presence of multiple simultaneous contrast agents. In contrast, the proposed method is capable of handling multiple simultaneous contrast agents, thus allowing suppression of 511 keV attenuation map inaccuracy.
Attenuation map produced by spectral CT clearly outperforms conventional single-kVp and dual-kVp approaches in the generation of accurate attenuation maps in the presence of multiple contrast agents.
KeywordsPET/CT Nanoparticulate contrast agents K-edge imaging Multi-energy spectral CT
This work was supported by Tehran University of Medical Sciences under Grant 21342 and the Swiss National Science Foundation under grant SNSF 31003A-149957.
- 3.Qu M, Ehman E, Fletcher JG, Huprich JE, Hara AK, Silva AC, et al. Toward biphasic computed tomography (CT) enteric contrast: material classification of luminal bismuth and mural iodine in a small-bowel phantom using dual-energy CT. J Comput Assist Tomogr. 2012;36(5):554–9.PubMedCrossRefGoogle Scholar
- 6.Reuveni T, Motiei M, Romman Z, Popovtzer A, Popovtzer R. Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study. Int J Nanomed. 2011;6:2859–64.Google Scholar
- 9.Axelsson O. Inventor contrast agents comprising tungsten-containing cores. European patent EP1893243. March 2008.Google Scholar
- 30.Zou Y, Silver MD, editors. Analysis of fast kV-switching in dual energy CT using a pre-reconstruction decomposition technique. Proceedings of the SPIE medical imaging: physics of medical imaging, San Diego, CA; 2008.Google Scholar
- 31.Carmi R, Naveh G, Altman A, editors. Material separation with dual-layer CT. IEEE nuclear science symposium conference record. Wyndham El Conquistador Resort, Puerto Rico: IEEE; Oct 2005. pp 23–29.Google Scholar
- 44.Walsh MF, Opie AMT, Ronaldson JP, Doesburg RMN, Nik SJ, Mohr JL, et al. First CT using Medipix3 and the MARS-CT-3 spectral scanner. J Instrum. 2011;6:C01095.Google Scholar
- 46.Ghadiri H, Ay MR, Shiran MB, Soltanian-Zadeh H, Zaidi H. K-edge ratio method for identification of multiple nanoparticulate contrast agents by spectral CT imaging. Br J Radiol. 1029;2013(86):20130308.Google Scholar
- 47.Cranley K, Gilmore B, Fogarty G, Desponds L, Sutton D. Catalogue of diagnostic x-ray spectra and other data. IPEM report 78. 1997.Google Scholar
- 48.Ghadiri H, Shiran MB, Soltanian-Zadeh H, Rahmim A, Ay MR. A fast and hardware-mimicking analytic CT simulator. IEEE nuclear science symposium and medical imaging conferenc, Korea; 2013.Google Scholar
- 51.Lonn AHR. Evaluation of method to minimize the effect of X-ray contrast in PET-CT attenuation correction. IEEE nuclear science symposium, conference record; 2004. pp. 2220–21.Google Scholar